Multifunctional nanoparticles for doxycycline delivery towards localized elastic matrix stabilization and regenerative repair

Acta Biomaterialia

Volumn 9, Issue 5, 2013, Pages 6511-6525

  Sivaraman, Balakrishnan ^a   Ramamurthi, Anand ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Drug delivery; Elastic matrix; Matrix metalloproteases (MMPs); Nanoparticles; Regenerative matrix repair

Indexed keywords

AMPHIPHILES; BLOOD VESSELS; CONTROLLED DRUG DELIVERY; ELASTIN; ENZYME ACTIVITY; ENZYME INHIBITION; GLYCOPROTEINS; HYDROPHOBICITY; PEPTIDES; TARGETED DRUG DELIVERY;

ABDOMINAL AORTIC ANEURYSMS; AORTIC WALLS; DOXYCYCLINE; ELASTIC MATRIX; LOCALISED; MATRIX METALLOPROTEASE; MATRIX METALLOPROTEASE 2; MATRIX REPAIR; REGENERATIVE MATRIX REPAIR;

NANOPARTICLES;

AMPHOPHILE; DOXYCYCLINE; ELASTIN; GELATINASE A; NANOPARTICLE; POLYGLACTIN; PROTEIN LYSINE 6 OXIDASE;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ELASTOLYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROPHOBICITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN PROTEIN INTERACTION; RAT; SMOOTH MUSCLE FIBER; STATIC ELECTRICITY; UPREGULATION;

ANIMALIA;

EID: 84879889853     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.01.023     Document Type: Article

References (79)

1. F.A. Lederle, G.R. Johnson, S.E. Wilson, E.P. Chute, F.N. Littooy, and D. Bandyk Prevalence and associations of abdominal aortic aneurysm detected through screening Ann Intern Med 126 1997 441 449
2. J.G. Selle, F. Robicsek, H.K. Daugherty, and J.W. Cook Thoracoabdominal aortic aneurysms: a review and current status Ann Surg 189 1979 158 164
3. A.N. Assar Pharmacological therapy for patients with abdominal aortic aneurysm Expert Rev Cardiovasc Ther 7 2009 999 1009
4. M. Rentschler, and B.T. Baxter Pharmacological approaches to prevent abdominal aortic aneurysm enlargement and rupture Ann NY Acad Sci 1085 2006 39 46
5. A. Daugherty, and L.A. Cassis Mechanisms of abdominal aortic aneurysm formation Curr Atheroscler Rep 4 2002 222 227
6. A. Daugherty, and L.A. Cassis Mouse models of abdominal aortic aneurysms Arterioscler Thromb Vasc Biol 24 2004 429 434
7. R. Pyo, J.K. Lee, J.M. Shipley, J.A. Curci, D.L. Mao, and S.J. Ziporin Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms J Clin Invest 105 2000 1641 1649
8. R. Hanemaaijer, H. Visser, P. Koolwijk, T. Sorsa, T. Salo, and L.M. Golub Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells Adv Dent Res 12 1998 114 118
9. J. Liu, W.F. Xiong, L. Baca-Regen, H. Nagase, and B.T. Baxter Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells J Vasc Surg 38 2003 1376 1383
10. V.J. Uitto, J.D. Firth, L. Nip, and L.M. Golub Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes R.A. Greenwald, L.M. Golub, Inhibition of matrix metalloproteinases: therapeutic potential 1994 New York Academy of Sciences New York 140 151
11. M.A. Bartoli, F.E. Parodi, J. Chu, M.B. Pagano, D.L. Mao, and B.T. Baxter Localized administration of doxycycline suppresses aortic dilatation in an experimental mouse model of abdominal aortic aneurysm Ann Vasc Surg 20 2006 228 236
12. J.A. Curci, D. Petrinec, S.X. Liao, L.M. Golub, and R.W. Thompson Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines J Vasc Surg 28 1998 1082 1093
13. M.W. Manning, L.A. Cassis, and A. Daugherty Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms Arterioscler Thromb Vasc Biol 23 2003 483 488
14. D. Petrinec, S.X. Liao, D.R. Holmes, J.M. Reilly, W.C. Parks, and R.W. Thompson Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kDa gelatinase J Vasc Surg 23 1996 336 346
15. A.K. Prall, G.M. Longo, W.G. Mayhan, E.A. Waltke, B. Fleckten, and R.W. Thompson Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice J Vasc Surg 35 2002 923 928
16. B.T. Baxter, W.H. Pearce, E.A. Waltke, F.N. Littooy, J.W. Hallett, and K.C. Kent Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study J Vasc Surg 36 2002 1 12
17. J.A. Curci, D.L. Mao, D.G. Bohner, B.T. Allen, B.G. Rubin, and J.M. Reilly Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms J Vasc Surg 31 2000 325 341
18. M. Mosorin, J. Juvonen, F. Biancari, J. Satta, H.M. Surcel, and M. Leinonen Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study J Vasc Surg 34 2001 606 610
19. L.M. Golub, N.S. Ramamurthy, T.F. McNamara, R.A. Greenwald, and B.R. Rifkin Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs Crit Rev Oral Biol Med 2 1991 297 322
20. G.N. Smith, K.D. Brandt, and K.A. Hasty Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity Arthritis Rheum 39 1996 235 244
21. E. Sho, J. Chu, M. Sho, B. Fernandes, D. Judd, and P. Ganesan Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms J Vasc Surg 39 2004 1312 1321
22. W.Y.C. Chang, D. Clements, and S.R. Johnson Effect of doxycycline on proliferation, MMP production, and adhesion in LAM-related cells Am J Physiol Lung Cell Mol Physiol 299 2010 L393 L400
23. C. Franco, B. Ho, D. Mulholland, G.P. Hou, M. Islam, and K. Donaldson Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices Am J Pathol 168 2006 1697 1709
24. V. Labhasetwar, C.X. Song, W. Humphrey, R. Shebuski, and R.J. Levy Arterial uptake of biodegradable nanoparticles: effect of surface modifications J Pharm Sci 87 1998 1229 1234
25. H.M. Kagan, D.E. Simpson, and L. Tseng Substrate-directed modulation of elastin oxidation by lysyl oxidase Connect Tissue Res 8 1981 213 217
26. H.M. Kagan, L. Tseng, and D.E. Simpson Control of elastin metabolism by elastin ligands. Reciprocal effects on lysyl oxidase activity J Biol Chem 256 1981 5417 5421
27. C.E. Gacchina, P.P. Deb, J.L. Barth, and A. Ramamurthi Elastogenic inductability of smooth muscle cells from a rat model of late stage abdominal aortic aneurysms Tissue Eng 17 2011 1699 1711
28. C.E. Gacchina, and A. Ramamurthi Impact of pre-existing elastic matrix on TGFβ1 and HA oligomer-induced regenerative elastin repair by rat aortic smooth muscle cells J Tissue Eng Regen Med 5 2011 85 96
29. C.R. Kothapalli, and A. Ramamurthi Induced elastin regeneration by chronically activated smooth muscle cells for targeted aneurysm repair Acta Biomater 6 2010 170 178
30. L.A. Guzman, V. Labhasetwar, C.X. Song, Y.S. Jang, A.M. Lincoff, and R. Levy Local intraluminal infusion of biodegradable polymeric nanoparticles-a novel approach for prolonged drug delivery after balloon angioplasty Circulation 94 1996 1441 1448
31. C.X. Song, V. Labhasetwar, H. Murphy, X. Qu, W.R. Humphrey, and R.J. Shebuski Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery J Control Release 43 1997 197 212
32. A.K. Davies, R.B. Cundall, Y. Dandiker, and M.A. Slifkin Photo-oxidation of tetracycline adsorbed on hydroxyapatite in relation to the light-induced staining of teeth J Dent Res 64 1985 936 939
33. V.C. Honnorat-Benabbou, A.A. Lebugle, B. Sallek, and D. Duffaut-Lagarrigue Stability study of tetracyclines with respect to their use in slow release systems J Mater Sci Mater Med 12 2001 107 110
34. C. Peetla, and V. Labhasetwar Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake Langmuir 25 2009 2369 2377
35. R. Injac, J. Kac, S. Kreft, and B. Strukelj Determination of doxycycline in pharmaceuticals and human urine by micellar electrokinetic capillary chromatography Anal Bioanal Chem 387 2007 695 701
36. S.S. Mitic, G.Z. Miletic, D.A. Kostic, D.C. Naskovic-Dokic, B.B. Arsic, and I.D. Rasic A rapid and reliable determination of doxycycline hyclate by HPLC with UV detection in pharmaceutical samples J Serb Chem Soc 73 2008 665 671
37. M. Sunder, N.R. Babu, S.P. Victor, K.R. Kumar, and T.S.S. Kumar Biphasic calcium phosphates for antibiotic release Trends Biomater Artif Organs 18 2005 213 218
38. M.C. Haerdi-Landerer, M.M. Suter, A. Steiner, M.M. Wittenbrink, A. Pickl, and B.A. Gander In vitro cell compatibility and antibacterial activity of microencapsulated doxycycline designed for improved localized therapy of septic arthritis J Antimicrob Chemother 61 2008 332 340
39. 2 reagent in aqueous solution J Anal Chem 64 2009 231 237
40. C. Labarca, and K. Paigen A simple, rapid, and sensitive DNA assay procedure Anal Biochem 102 1980 344 352
41. L. Venkataraman, and A. Ramamurthi Induced elastin matrix generation within 3-dimensional collagen scaffolds Tissue Eng Part A 17 2011 2879 2889
42. A.H. Palamakumbura, and P.C. Trackman A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples Anal Biochem 300 2002 245 251
43. C.E. Astete, and C.M. Sabliov Synthesis and characterization of PLGA nanoparticles J Biomater Sci Polym Ed 17 2006 247 289
44. J.-M. Lue, X. Wang, C. Marin-Muller, H. Wang, P.H. Lin, and Q. Yao Current advances in research and clinical applications of PLGA-based nanotechnology Expert Rev Mol Diagn 9 2009 325 341
45. J. Panyam, M.A. Dali, S.K. Sahoo, W.X. Ma, S.S. Chakravarthi, and G.L. Amidon Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano and microparticles J Control Release 92 2003 173 187
46. G. Wang, and H. Uludag Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles Expert Opin Drug Deliv 5 2008 499 515
47. S.K. Sahoo, J. Panyam, S. Prabha, and V. Labhasetwar Residual polyvinyl alcohol associated with poly(d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake J Control Release 82 2002 105 114
48. K.T. Nguyen, K.P. Shukla, M. Moctezuma, A.R.C. Braden, J. Zhou, and Z.B. Hu Studies of the cellular uptake of hydrogel nanospheres and microspheres by phagocytes, vascular endothelial cells, and smooth muscle cells J Biomed Mater Res 88A 2009 1022 1030
49. A.J. Thote, J.T. Chappell, R.B. Gupta, and R. Kumar Reduction in the initial-burst release by surface crosslinking of PLGA microparticles containing hydrophilic or hydrophobic drugs Drug Dev Ind Pharm 31 2005 43 57
50. Y. Yeo, and K.N. Park Control of encapsulation efficiency and initial burst in polymeric microparticle systems Arch Pharm Res 27 2004 1 12
51. M.P. Bendeck, M. Conte, M.Y. Zhang, N. Nili, B.H. Strauss, and S.M. Farwell Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury Am J Pathol 160 2002 1089 1095
52. R. Ding, C.L. McGuinness, K.G. Burnand, E. Sullivan, and A. Smith Matrix metalloproteinases in the aneurysm wall of patients treated with low-dose doxycycline Vascular 13 2005 290 297
53. S.P. Pinney, H.J. Chen, D.X. Liang, X.Y. Wang, A. Schwartz, and L.E. Rabbani Minocycline inhibits smooth muscle cell proliferation, migration and neointima formation after arterial injury J Cardiovasc Pharmacol 42 2003 469 476
54. Q.H. Meng, J.W. Xu, I.D. Goldberg, E.M. Rosen, R.A. Greenwald, and S.J. Fan Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells Clin Exp Metastasis 18 2000 139 146
55. R.E.B. Seftor, E.A. Seftor, J.E. De Larco, D.E. Kleiner, J. Leferson, and W.G. Stetler-Stevenson Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis Clin Exp Metastasis 16 1998 217 225
56. J.M. TeKoppele, B. Beekman, N. Verzijl, J.L. Koopman, J. DeGroot, and R.A. Bank Doxycycline inhibits collagen synthesis by differentiated articular chondrocytes Adv Dent Res 12 1998 63 67
57. C. Chen, F. Loe, A. Blocki, Y. Peng, and M. Raghunath Applying macromolecular crowding to enhance extracellular matrix deposition and its remodeling in vitro for tissue engineering and cell-based therapies Adv Drug Deliv Rev 63 2011 277 290
58. Y. Peng, and M. Raghunath Learning from Nature: emulating macromolecular crowding to drive extracellular matrix enhancement for the creation of connective tissue D. Eberli, Tissue engineering 2010 InTech Vukovar 103 118
59. A. Hinek, R.P. Mecham, F. Keeley, and M. Rabinovitch Impaired elastin fiber assembly related to reduced 67-kDa elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate J Clin Invest 88 1991 2083 2094
60. A. Hinek, and M. Rabinovitch 67-kDa elastin-binding protein is a protective "companion" of extracellular insoluble elastin and intracellular tropoelastin J Cell Biol 126 1994 563 574
61. R.E. Jordan, N. Hewitt, W. Lewis, H. Kagan, and C. Franzbla Regulation of elastase-catalyzed hydrolysis of insoluble elastin by synthetic and naturally occurring hydrophobic ligands Biochemistry 13 1974 3497 3503
62. H.M. Kagan, K.A. Sullivan, T.A. Olsson, and A.L. Cronlund Purification and properties of four species of lysyl oxidase from bovine aorta Biochem J 177 1979 203 214
63. G.M. Longo, W.F. Xiong, T.C. Greiner, Y. Zhao, N. Fiotti, and B.T. Baxter Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms J Clin Invest 110 2002 625 632
64. V. Davis, R. Persidskaia, L. Baca-Regen, Y. Itoh, H. Nagase, and Y. Persidsky Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms Arterioscler Thromb Vasc Biol 18 1998 1625 1633
65. S. Galindo-Rodriguez, E. Allemann, H. Fessi, and E. Doelker Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods Pharm Res 21 2004 1428 1439
66. R.A. Garcia, D.P. Pantazatos, C.R. Gessner, K.V. Go, V.L. Woods, and F.J. Villarreal Molecular interactions between matrilysin and the matrix metalloproteinase inhibitor doxycycline investigated by deuterium exchange mass spectrometry Mol Pharmacol 67 2005 1128 1136
67. E. Mendis, M.-M. Kim, N. Rajapakse, and S.-K. Kim The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions Bioorg Med Chem Lett 19 2009 2755 2759
68. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases-structure, function, and biochemistry Circ Res 92 2003 827 839
69. A. Tezvergil-Mutluay, K.A. Agee, T. Uchiyama, S. Imazato, M.M. Mutluay, and M. Cadenaro The inhibitory effects of quaternary ammonium methacrylates on soluble and matrix-bound MMPs J Dent Res 90 2011 535 540
70. B. Ganguly, J. Banerjee, A.I. Elegbede, D.J. Klocke, S. Mallik, and D.K. Srivastava Intrinsic selectivity in binding of matrix metalloproteinase-7 to differently charged lipid membranes FEBS Lett 581 2007 5723 5726
71. R. Atkin, V.S.J. Craig, E.J. Wanless, and S. Biggs Mechanism of cationic surfactant adsorption at the solid-aqueous interface Adv Colloid Interface Sci 103 2003 219 304
72. K. Esumi, M. Matoba, and Y. Yamanaka Characterization of adsorption of quaternary ammonium cationic surfactants and their adsolubilization behaviors on silica Langmuir 12 1996 2130 2135
73. K. Esumi, K. Taguma, and Y. Koide Aqueous properties of multichain quaternary cationic surfactants Langmuir 12 1996 4039 4041
74. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv Drug Deliv Rev 55 2003 329 347
75. J. Panyam, and V. Labhasetwar Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles Mol Pharm 1 2004 77 84
76. J. Panyam, W.Z. Zhou, S. Prabha, S.K. Sahoo, and V. Labhasetwar Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery FASEB J 16 2002 1217 1226
77. N. Sperelakis Membrane potential, transport physiology, pumps, and exchangers Cell physiology source book: essentials of membrane biophysics 4th ed. 2011 Academic Press New York
78. H.M. Kagan, and W.D. Li Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell J Cell Biochem 88 2003 660 672
79. Y. Chau, F.E. Tan, and R. Langer Synthesis and characterization of dextran-peptide-methotrexate conjugates for tumor targeting via mediation by matrix metalloproteinase II and matrix metalloproteinase IX Bioconjug Chem 15 2004 931 941